Lenz & Staehelin advised Zurich-based Signa European Invest Holding and its subsidiaries, as the former holding company of participations in department stores Selfridges, Globus and KaDeWe has concluded a debt restructuring agreement with its creditors,
Tags :Lenz & Staehelin
Lenz & Staehelin represents Swiss ticketing company Ticketcorner and concert venue Hallenstadion Zürich as, after a judgment of the Swiss Federal Supreme Court in 2020, the Swiss Competition Commission has imposed low fines on both
Lenz & Staehelin advised Veeam Software — a portfolio company of Insight Partners specialised in the development of data backup, data recovery and data protection solutions — in connection with its acquisition of Object First, a provider
French healthcare group Emeis has signed agreements with buyer Tertianum for the sale of Senevita, its Swiss residential and nursing home business. In connection with the deal, Bär & Karrer advised Tertianum, while Lenz &
Lenz & Staehelin ETF and ETP provider WisdomTree in connection with the listing of a new ETP on liquid staking token Lido Staked Ether. The vehicle trades on SIX Swiss Exchange as of December 4, 2025. The
Lenz & Staehelin advises Vodafone Group as the telecommunication multinational agreed to acquire German digital transformation and security specialist Skaylink Group, primarily from funds managed by private equity firm Waterland. Closing is planned for the
Lenz & Staehelin advised Swiss cybersecurity firm Monti Stampa Furrer & Partners (MSF Partners) and its shareholders in connection with the company’s sale to Stockholm-based Allurity, also active in the cibersecurity sector. About MSF
Lenz & Staehelin advised fintech platform Leverage Shares in connection with the recent listing of its new triple-leveraged long and short ETPs on Bitcoin and Ethereum on SIX Swiss Exchange. The ETPs in
Lenz & Staehelin expands its partnership with the appointment of Federico Trabaldo Togna, effective January 1st 2026. The firm further promoted three new counsels: Jutta Gangsted, Tanja Schmidt and Norman Walczak, also effective from January 1st.
Globally active biopharmaceutical company AstraZeneca has exercised an option to acquire obesity drug startup SixPeaks Bio. In connection with the deal, Lenz & Staehelin represented AstraZeneca, while Walder Wyss advised SixPeaks Bio and its shareholders.